On June 29th, 2020, while America remained transfixed by anti-police protests, the chairman and CEO of the pharmaceutical company Gilead ... Daniel O’Day explained how much his company planned on charging for a course of remdesivir, one of many possible treatments for Covid-19....O’Day wrote...a masterpiece of corporate doublespeak (with the) hilarious implication seemed to be that by shortening hospital stays by four days on average, remdesivir was worth $48,000 a dose.... Gilead became infamous a few years ago for charging $84,000 per course of treatment for Sovaldi, a groundbreaking hepatitis-C drug.
About This Quote
About Matt Taibbi
Matt Taibbi was a contemporary American author and journalist. Matthew Colin Taibbi is an American author, journalist and podcaster. A former contributing editor for Rolling Stone, he is the author of several books and publisher of Racket News. Read more on Wikipedia →